Endocrine and Metabolic Management in the Cardiothoracic ICU

Endocrine and Metabolic Management in the Cardiothoracic ICU

Rifka C. Schulman (Long Island Jewish Medical Center, USA) and Jeffrey I. Mechanick (Icahn School of Medicine at Mount Sinai, USA)
Copyright: © 2015 |Pages: 28
DOI: 10.4018/978-1-4666-8603-8.ch021
OnDemand PDF Download:
No Current Special Offers


In this chapter, we review several important endocrine disorders frequently encountered in patients undergoing cardiothoracic surgery. Hyperglycemia, common in patients with and without diabetes mellitus (DM) in the perioperative period, has been linked to poor outcomes. Use of an intravenous insulin infusion early in the postoperative course, followed by transition to subcutaneous insulin, with maintenance of moderate glycemic targets (100-180 mg/dL) is currently the standard of care. Oral intake should be encouraged in the postoperative period, but if not possible, nutrition support with enteral nutrition should be considered. Critical illness related corticosteroid insufficiency (CIRCI) should be suspected in critically ill patients with refractory hypotension requiring vasopressors, especially in the setting of septic shock. Although diagnositic criteria are controversial, if suspected, empiric treatment with corticosteroids should be initiated. Nonthyroidal illness syndrome (NTIS) is common in critically ill patients and thyroid function tests should be interpreted with caution in this population.
Chapter Preview


While significant and recent advances in cardiothoracic surgical care have optimized patient outcomes, these patients sustain varying degrees of critical illness in the post-operative period. From a metabolic perspective, patients can be understood in terms of four sequential stages of critical illness, each with a unique hormonal and metabolic milieu: acute critical illness (ACI), prolonged acute critical illness (PACI), chronic critical illness (CCI), and recovery from critical illness (RCI) (Hollander & Mechanick, 2006; Schulman & Mechanick, 2012).

ACI follows a stressor (e.g., surgery, infection, or trauma) that triggers the “stress response,” characterized by enhanced secretion of “stress hormones” (e.g., cortisol, glucagon, and growth hormone), catecholamines, and cytokines (tumor necrosis factor-α [TNF-α], interleukin-1 [IL-1], and interleukin-6 [IL-6]) (Singer, De Santis, & Vitale, 2004). Increased levels of cytokines shift reverse-phase reactants (e.g., albumin, transferrin, and cortisol-binding globulin) to acute-phase reactants (e.g., C-reactive protein and immunoglobulins). This hormonal milieu diverts substrates from anabolic to catabolic pathways, stimulating gluconeogenesis, lipolysis, and proteolysis of skeletal muscle, while inhibiting peripheral glucose uptake, to ensure an adequate supply of substrates (Chang & Bistrian, 1998; Marques, & Langouche, 2012). These metabolic changes create a state of insulin resistance, frequently leading to hyperglycemia in critically ill patients (Mechanick, 2006).

PACI, beginning at around day 3 of critical illness, is characterized by a persistent stress response, with maintenance of inflammation, catabolism, and insulin resistance. While ACI is considered an adaptive response, conferred by evolutionary mechanisms, the persistence of critically ill patients in the intensive care unit (ICU), repeatedly avoiding death by artificial means, is largely due to technological innovations, which have no evolutionary precedent. Persistent immune-neuroendocrine (INA) output results in excessive tissue breakdown, hyperglycemia, and hypoalbuminemia.

CCI, beginning with tracheotomy at around day 10-14 of critical illness, represents a unique maladaptive physiological state characterized by prolonged mechanical ventilation, kwashiorkor-like malnutrition, stress hyperglycemia, neuroendocrine dysfunction, impaired wound healing, immune deficiency, metabolic bone disease, critical illness myopathy and polyneuropathy, neurocognitive dysfunction, and excessive symptom burden for patients (Hollander & Mechanick, 2006; Nelson, Meier, & Litke, 2004).

Complete Chapter List

Search this Book: